Law360, New York (November 03, 2009) -- Calling the inquiries “irrelevant and inappropriate,” Sanofi-Aventis SA and Bristol-Myers Squibb Co. have sought to snuff out six subpoenas issued by generic-drug maker Apotex Inc. in connection with settlement amount determinations in a patent infringement dispute over blockbuster blood thinner Plavix.
Sanofi and Bristol-Myers, which both have an interest in Plavix, filed motions to quash the subpoenas Monday in the U.S. District Court for the Southern District of New York, saying...
